Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Free Cash Flow: 2018-2024

Historic Free Cash Flow for Silence Therapeutics (SLN) over the last 7 years, with Dec 2024 value amounting to -$67.9 million.

  • Silence Therapeutics' Free Cash Flow rose 57.53% to -$10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$72.6 million, marking a year-over-year decrease of 15.70%. This contributed to the annual value of -$67.9 million for FY2024, which is 37.02% down from last year.
  • According to the latest figures from FY2024, Silence Therapeutics' Free Cash Flow is -$67.9 million, which was down 37.02% from -$49.5 million recorded in FY2023.
  • Silence Therapeutics' 5-year Free Cash Flow high stood at $7.6 million for FY2021, and its period low was -$67.9 million during FY2024.
  • In the last 3 years, Silence Therapeutics' Free Cash Flow had a median value of -$57.2 million in 2022 and averaged -$58.2 million.
  • In the last 5 years, Silence Therapeutics' Free Cash Flow crashed by 937.42% in 2020 and then surged by 141.16% in 2021.
  • Silence Therapeutics' Free Cash Flow (Yearly) stood at -$18.4 million in 2020, then skyrocketed by 141.16% to $7.6 million in 2021, then slumped by 856.79% to -$57.2 million in 2022, then increased by 13.46% to -$49.5 million in 2023, then crashed by 37.02% to -$67.9 million in 2024.